This study sought to answer the question of how much oxyen your patients are inspiring with different devices, with and without tachypea. They simulated tachypnea in healthy volunteers (by chest binding) and measured the Fi02 in the hypopharynx before and after tachypnea (RR>25). They found the Fi02 decreased by 12-24% in rebreathing masks after tachypnea, but did not change in non-rebreathing masks after tachypnea. However, they did find the hypopharynx Fi02 was only 68% in non-rebreathing masks (indicating the term “100% non-rebreather” is a misnomer). It is very important to know the amount of Fi02 your patients are actually inspiring, and to note that it significantly decreases with tachypnea in rebreather devices (abstract).
Share This Post
Categories
Related Posts
While spring 2020 feels like a lifetime ago, COVID-19 is still with us. Unfortunately, this winter has brought more infections, hospitalizations, and death rates that eclipse what many saw last spring. But this time, while the headlines are back about hospitals running low on PPE, ICU bed shortages, and long lines for testing, we now […]
This article is part of a series in The Hospital Leader written by members of the Division of Hospital Medicine at Dell Medical School at The University of Texas in Austin, exploring lessons learned from the coronavirus pandemic and outlining an approach for creating COVID-19 Centers of Excellence. Evidence on emerging treatments for COVID-19 has […]
While all of us see patients who smoke in their 70s or 80s, due to their limited lifespan from COPD, DM, malignancy, etc., and their expressed wishes to continue tobacco, we keep our admonitions to a minimum. We accept our patient has become learned enough through life to make their own decisions and accept whatever […]
Leave A Comment